Dr Jayaprakash P Muliyil, chairperson of the Data and Safety Monitoring Board of the SII trial stated that this was “not studied during or even after licensing.”
At least two studies done in other countries identified significantly heavier-than-normal menstrual bleeding among women after their Covid-19 vaccines.
“We should be probably focusing on this. But the mechanism in terms of evolutionary biology in terms of women is much more hardy, so these things won’t affect them.”